Results 71 to 80 of about 28,276 (143)

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine in patients with e antigen positive chronic hepatitis B

Revista Cubana de Medicina, 2007
Las tasas de seroconversión del antígeno e alcanzadas con los antivirales actuales no sobrepasan el 35 %. La combinación de inmunomodulador y antiviviral ha sido teóricamente la estrategia más aceptada en los últimos años; sin embargo, los resultados en ...
Eduardo Vilar Gómez, Bienvenido Grá Orama, Enrique Arús Soler, Caridad Ruenes Domech, Yudith Dávila González   +4 more
doaj  

Treatment of patients with chronic hepatitis b in General hospital Celje

Zdravniški Vestnik, 2005
Background: A third of world’s population has serological evidence of a past or current infection with hepatitis B virus and 350 million people have chronic infection. Chronic hepatitis B is associated with liver cirrhosis and hepatic cancer, i.e.
Gorazd Lešničar
doaj  

Clinical and biological risk factors influencing infant HIV status: a case study of Kisenyi Health Center IV, Kampala, Uganda. [PDF]

BMC Infect Dis
Bagonza FX, Asiimwe JB, Wamono F, Nsimbe D.   +3 more
europepmc   +1 more source

Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]

Einstein (Sao Paulo)
Zanardo LW, Izabel LDS, Hamada LM, Carvalho MB, Silva PAGOE, Joaquim HDG, Santoro S, Festuccia WT, Magdalon J.   +8 more
europepmc   +1 more source

Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV. [PDF]

J Health Econ Outcomes Res
Chastek B, Mordi U, Christoph MJ, Le LB, Lim T, Majethia S, Trom C, Cohen J.   +7 more
europepmc   +1 more source

Anti-inflammatory effect of lamivudine on ulcerative colitis. [PDF]

Biochem Biophys Rep
Chen X, Wang H, Liu Y, Zhang W, Song Z.
europepmc   +1 more source

Bis-prodrug cryopreserved lipid nanoparticles with enzymatically triggered release. [PDF]

Nanoscale Adv
Hogarth C, Arnold K, Elkateb H, Rannard S, McDonald TO.   +4 more
europepmc   +1 more source

Negative influence of age and low baseline CD4 on T helper cell recovery among HIV-infected individuals with fixed-dose combination of tenofovir disoproxil, lamivudine and dolutegravir. [PDF]

Front Public Health
Saravanan S, Vignesh R, Rengarajan S, Vivekanandan T, Yong YK, Varsha V, Mounika P, Sivamalar S, Vidya M, Shankar EM, Larsson M, Velu V, Raju S, Balakrishnan P, Nisha B, Venkateswaran AR, Kannan R.   +16 more
europepmc   +1 more source

Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Chu YD, Ho PH, Hsu CW, Chiou CY, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source

Mental health disorders among people living with human immunodeficiency virus on antiretroviral therapy in Benin: the overlooked role of sleep quality. [PDF]

J Glob Health
Ale BM, Assogba CO, Dansou E, Ale OAJ, Koutangni OL, Alogou ARK, Akpi SG, Damassoh KGD, Youm E, Wakaba NN, Assogba HMA, Agbodande KA, Kouanou AA, Ale FBG.   +13 more
europepmc   +1 more source